Relmada Therapeutics, Inc. (RLMD)

3.90 -0.06 (-1.52%) USD  |  NASDAQ  |  Jan 23, 16:00
3.91 +0.01 (+0.26%) After-Hours: 20:00
More

Relmada Therapeutics Market Cap Per Employee (Annual)

Market Cap Per Employee (Annual) Chart

View Market Cap Per Employee (Annual) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Market Cap Per Employee (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Market Cap Per Employee (Annual) Range, Past 5 Years

View Market Cap Per Employee (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Market Cap Per Employee (Annual) Benchmarks

View Market Cap Per Employee (Annual) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade
Arcellx, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade